INS and type 2 diabetes mellitus: Thus use of insulin analogs may have dual effects in type 2 diabetes: decreasing cancer risk by improving metabolic control but simultaneously increasing cancer risk, because of its dose-dependent effects on cell growth and proliferation (37) (Figure 4).